about
Comparison of bioavailability of krill oil versus fish oil and health effectSuggestive evidence of associations between liver X receptor β polymorphisms with type 2 diabetes mellitus and obesity in three cohort studies: HUNT2 (Norway), MONICA (France) and HELENA (Europe).Bioavailability of n-3 fatty acids from n-3-enriched foods and fish oil with different oxidative quality in healthy human subjects: a randomised single-meal cross-over study.Severe hypertriglyceridemia in Norway: prevalence, clinical and genetic characteristics.Sun exposure induces rapid immunological changes in skin and peripheral blood in patients with psoriasis.Substitution of TAG oil with diacylglycerol oil in food items improves the predicted 10 years cardiovascular risk score in healthy, overweight subjects.Children and young adults with familial hypercholesterolaemia (FH) have healthier food choices particularly with respect to dietary fat sources compared with non-FH childrenFish oil supplementation alters the plasma lipidomic profile and increases long-chain PUFAs of phospholipids and triglycerides in healthy subjectsFish oil supplementation induces expression of genes related to cell cycle, endoplasmic reticulum stress and apoptosis in peripheral blood mononuclear cells: a transcriptomic approachEffect of marine n-3 fatty acids on circulating inflammatory markers in healthy subjects and subjects with cardiovascular risk factorsIncreased systemic and local interleukin 9 levels in patients with carotid and coronary atherosclerosisFructose content of low calorie diets: effect on cardiometabolic risk factors in obese women with polycystic ovarian syndrome: a randomized controlled trial.Data on circulating leukocyte subpopulations and inflammatory proteins in children with familial hypercholesterolemia and healthy children.Altered expression of genes involved in lipid metabolism in obese subjects with unfavourable phenotype.Effects of a healthy Nordic diet on gene expression changes in peripheral blood mononuclear cells in response to an oral glucose tolerance test in subjects with metabolic syndrome: a SYSDIET sub-study.The PBMC transcriptome profile after intake of oxidized versus high-quality fish oil: an explorative study in healthy subjects.Lack of Effects of a Single High-Fat Meal Enriched with Vegetable n-3 or a Combination of Vegetable and Marine n-3 Fatty Acids on Intestinal Peptide Release and Adipokines in Healthy Female SubjectsLIGHT/TNFSF14 is increased in patients with type 2 diabetes mellitus and promotes islet cell dysfunction and endothelial cell inflammation in vitro.Subjects with low plasma HDL cholesterol levels are characterized by an inflammatory and oxidative phenotype.Gene expression is differentially regulated in skeletal muscle and circulating immune cells in response to an acute bout of high-load strength exercise.Markers of atherosclerotic development in children with familial hypercholesterolemia: a literature review.High-quality fish oil has a more favourable effect than oxidised fish oil on intermediate-density lipoprotein and LDL subclasses: a randomised controlled trial.Does intrauterine exposure to hypercholesterolemia adversely affect familial hypercholesterolemia phenotype?Exchanging a few commercial, regularly consumed food items with improved fat quality reduces total cholesterol and LDL-cholesterol: a double-blind, randomised controlled trial.Increased expression of NAMPT in PBMC from patients with acute coronary syndrome and in inflammatory M1 macrophages.Interleukin-10 increases reverse cholesterol transport in macrophages through its bidirectional interaction with liver X receptor α.Altered leukocyte distribution under hypercholesterolemia: A cross-sectional study in children with familial hypercholesterolemia.LDL cholesterol in early pregnancy and offspring cardiovascular disease risk factors.Cholesterol efflux mediators in homozygous familial hypercholesterolemia patients on low-density lipoprotein apheresis.Cardiovascular disease mortality in patients with genetically verified familial hypercholesterolemia in Norway during 1992-2013.Cardiovascular disease in patients with genotyped familial hypercholesterolemia in Norway during 1994-2009, a registry study.Triglyceride-rich HDL3 from patients with familial hypercholesterolemia are less able to inhibit cytokine release or to promote cholesterol efflux.Increased levels of C-reactive protein and interleukin-6 in hyperhomocysteinemic subjects.Dietary counseling is associated with an improved lipid profile in children with familial hypercholesterolemia.Maternal inheritance does not predict cholesterol levels in children with familial hypercholesterolemia.Comprehensive lipid and metabolite profiling of children with and without familial hypercholesterolemia: A cross-sectional study.Subjects with familial hypercholesterolemia are characterized by an inflammatory phenotype despite long-term intensive cholesterol lowering treatment.Does dietary fat affect inflammatory markers in overweight and obese individuals?-a review of randomized controlled trials from 2010 to 2016.Effects of Exercise on Gene Expression of Inflammatory Markers in Human Peripheral Blood Cells: A Systematic Review.Marine n-3 Fatty Acids and Gene Expression in Peripheral Blood Mononuclear Cells.
P50
Q26781855-88CE6EA0-494B-4EB8-A316-9E8E7ABEBA2CQ33715779-644A516A-A58D-41B4-A193-34ACBC094748Q33782239-81EA0841-8F4B-4FF3-B7F9-63FCB4305C51Q33791924-144A1F6C-407D-4B05-A19D-1BBD508DE6CEQ34025504-E2073285-24E0-4811-9A24-8C033D85BB7AQ34126000-CA73A471-67E7-4F36-BF5B-82B382B02A2DQ34126112-B1DD30A4-63F6-4B7B-9B3F-92AE30A07B7EQ34404742-FA043A74-547E-4FD4-A673-5EBEABCBB44FQ34678652-02844F62-39AC-4FBE-9E99-0EC38BE73ABAQ34680900-8D188D55-D2CE-4733-AC30-27C114EDF734Q34983608-2CC8AE6B-F5C8-4ED2-88E4-FA6EFBAB07C6Q35808764-63D5204D-5808-4B42-9B89-518F413053FFQ36245157-711F4E63-3EF4-4F15-B656-518AC09D17F1Q36947539-6BA61CF6-BDBE-4906-8669-6DD9FD865B10Q37123153-4212FC9E-15A0-474C-970F-EC1CE98DC358Q37142034-A39476F3-059D-4350-A29F-38A9285E6F18Q37218440-C5585D56-B8A9-423B-ABEC-82AE8BFEEDA2Q37242976-25452D27-1299-42B4-B6F2-FAE14F38C031Q37297571-624D3FE4-BB54-49B4-BAA3-A4F7F3363835Q37679188-AC7EA46F-E417-4BA2-8DD0-4DC08E22DA1EQ38218468-FE28E2DF-4F75-43CD-A52E-6717E3017473Q38677100-A25F6477-931C-4E41-8386-4E1B385B23BFQ38806017-3A6F2570-4FBC-45A1-925E-2BBC773E5C8BQ38808420-B701DDE5-CD73-432E-9B27-2C608732E34EQ38832892-5501B30D-D0C3-47EC-A023-0792513603ACQ38974452-473B8773-9391-4FBB-B72E-D46A77D8035CQ39064202-17D996F8-1AD2-4851-AF39-1F615E30690DQ39129455-44BF13C5-5AE7-4081-8433-4E626890F0CDQ39193513-1E032A9F-D699-46AB-86F1-EDBD6DE39646Q39236327-076C600F-98F6-450E-B84C-D867E2902FB0Q39455589-CF6ECF2E-6CE5-4FB2-97F7-3ABBD26E32DAQ40301962-45B1DBD9-AF17-430C-84D2-FB6F486A1F3AQ40352345-A8E5E456-93CD-44FE-B6BF-F74C5226496FQ40634562-EAF20C40-E19F-41AB-AE7C-3869AA6B1CFAQ40991292-3E385424-E3E3-419F-970D-B3EBB99F5494Q41992684-3510ED17-A61F-44B4-959E-DBC837A2AAB2Q42228228-74422A96-7A1E-47F2-B0B9-7E4ECE901F0AQ42370498-6D14BD96-F7F7-41BD-8663-4DA051BBE879Q42541546-5F9A1753-A2EB-4BF7-8B73-B6B7D07A76F9Q42918063-725388E9-FF5F-4C7C-8B93-A9FD010D0C02
P50
description
Noors onderzoekster
@nl
norsk professor
@nb
researcher ORCID ID = 0000-0002-8674-9703
@en
name
Kirsten B Holven
@ast
Kirsten B Holven
@es
Kirsten B Holven
@nl
Kirsten B Holven
@sl
Kirsten B. Holven
@da
Kirsten B. Holven
@de
Kirsten B. Holven
@en
Kirsten B. Holven
@fr
Kirsten B. Holven
@ga
Kirsten B. Holven
@nb
type
label
Kirsten B Holven
@ast
Kirsten B Holven
@es
Kirsten B Holven
@nl
Kirsten B Holven
@sl
Kirsten B. Holven
@da
Kirsten B. Holven
@de
Kirsten B. Holven
@en
Kirsten B. Holven
@fr
Kirsten B. Holven
@ga
Kirsten B. Holven
@nb
altLabel
Kirsten B Holven
@en
Kirsten Bjørklund Holven
@en
Kirsten Bjørklund Holven
@nb
Kirsten Holven
@en
Kirsten Holven
@nb
prefLabel
Kirsten B Holven
@ast
Kirsten B Holven
@es
Kirsten B Holven
@nl
Kirsten B Holven
@sl
Kirsten B. Holven
@da
Kirsten B. Holven
@de
Kirsten B. Holven
@en
Kirsten B. Holven
@fr
Kirsten B. Holven
@ga
Kirsten B. Holven
@nb
P214
P2038
Kirsten_Holven
P21
P214
P2287
P27
P31
P496
0000-0002-8674-9703
P569
1963-01-01T00:00:00Z
P735
P7859
viaf-316781685